Glanbia Nutritionals has acquired Sterling Technology, a US-based manufacturer of dairy bioactive solutions derived from bovine colostrum, for $60m plus deferred consideration.
Colostrum is an ingredient used in the immunity and gut health segments of the health and wellness market. It’s well established in multiple markets, particularly Asia markets with a focus on paediatric and medical nutrition, dietary supplements, and sports nutrition.
“The acquisition of Sterling Technology enhances our bioactive solutions portfolio to support our customers’ needs and growth ambitions,” said Glanbia Nutritionals CEO Brian Phelan. “We are excited to bring on board the Sterling team and their expertise with this highly beneficial ingredient.”
Founded in 1987, the South Dakota based Sterling Technology employs approximately 60 employees.
